-
Featured
New Strategies for Heart Failure Patients Improves Outcomes
One-third of heart failure patients do not respond to cardiac resynchronization therapy (CRT) | A coordinated care approach at Mass General for heart failure patients improves outcomes.
-
Featured
The Promise of Ventricular-Assist Devices (VADs)
VAD technology is continually improving. Mass General data indicates new VADs improve 5-year survival rates. Trials for the latest generation are under way.
-
Reverse Cardiac Remodeling May Underlie Benefit of Sacubitril/Valsartan in HFrEF
An exploratory analysis of the PROVE-HF trial of sacubitril/valsartan showed that reductions in biomarkers of myocardial injury correlate with improvements in cardiac remodeling in patients with chronic heart failure—and biomarkers may be capable of guiding short-term follow-up care.
-
Infection of the Heart Commonly Seen at Autopsy of Patients Who Died of COVID-19
In the most detailed study to date, Mayara Bearse, MD, and James R. Stone, MD, PhD, of the Department of Pathology, and colleagues, cardiac infection by SARS-CoV-2 was evident in 73% of autopsies of patients who died of COVID-19 and was linked to differences in clinical features and treatment.
-
Age Influences the Effect of Risk Factors on Development of Heart Failure
Traditional risk factors have greater discriminatory value in predicting new onset of heart failure in younger adults than in older people, according to a pooled population-based cohort study by Samantha M.A. Paniagua, Sanjiv J. Shah, MD, and Jennifer E. Ho, MD, of the Cardiovascular Research Center, and colleagues.
-
Metabolic Cost of Exercise Initiation Higher in HFpEF
Ravi V. Shah, MD, and Gregory D. Lewis, MD, of the Corrigan Minehan Heart Center, and colleagues have defined a new measure, "internal work"—the metabolic cost of initiating movement—that may direct noncardiac therapy for exercise intolerance in patients who have heart failure with preserved ejection fraction.
Heart Failure Contributors
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Reverse Cardiac Remodeling May Underlie Benefit of Sacubitril/Valsartan in HFrEF
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
